<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18057246</PMID><DateCompleted><Year>2008</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>82</Volume><Issue>4</Issue><PubDate><Year>2008</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model.</ArticleTitle><Pagination><StartPage>1787</StartPage><EndPage>1797</EndPage><MedlinePgn>1787-97</MedlinePgn></Pagination><Abstract><AbstractText>Enterovirus 71 (EV71) is a causative agent of hand, foot, and mouth disease and is also associated with serious neurological disorders. An attenuated EV71 strain [EV71(S1-3')] has been established in the cynomolgus monkey infection model; this strain contains the attenuation determinants derived from the type 1 poliovirus vaccine strain, Sabin 1 [PV1(Sabin)], in the 5' nontranslated region (NTR), 3D polymerase, and 3' NTR. In this study, we analyzed the effect of the attenuation determinants of PV1(Sabin) on EV71 infection in a NOD/SCID mouse infection model. We isolated a mouse-adapted EV71 strain [EV71(NOD/SCID)] that causes paralysis of the hind limbs in 3- to 4-week-old NOD/SCID mice by adaptation of the virulent EV71(Nagoya) strain in the brains of NOD/SCID mice. A single mutation at nucleotide 2876 that caused an amino acid change in capsid protein VP1 (change of the glycine at position 145 to glutamic acid) was essential for the mouse-adapted phenotype in NOD/SCID mice. Next, we introduced attenuation determinants derived from PV1(Sabin) along with the mouse adaptation mutation into the EV71(Nagoya) genome. In 4-week-old mice, the determinants in the 3D polymerase and 3' NTR, which are the major temperature-sensitive determinants, had a strong effect on attenuation. In contrast, the effect of individual determinants was weak in 3-week-old NOD/SCID mice, and all the determinants were required for substantial attenuation. These results suggest that a cooperative effect of the attenuation determinants of PV1(Sabin) is essential for attenuated neurovirulence of EV71.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arita</LastName><ForeName>Minetaro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Virology II, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama-shi, Tokyo 208-0011, Japan. minetaro@nih.go.jp</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ami</LastName><ForeName>Yasushi</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Wakita</LastName><ForeName>Takaji</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014613">Vaccines, Attenuated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016688" MajorTopicYN="N">Mice, Inbred NOD</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016513" MajorTopicYN="N">Mice, SCID</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014613" MajorTopicYN="N">Vaccines, Attenuated</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>12</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>3</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>12</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2008</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18057246</ArticleId><ArticleId IdType="pmc">PMC2258712</ArticleId><ArticleId IdType="doi">10.1128/JVI.01798-07</ArticleId><ArticleId IdType="pii">JVI.01798-07</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arita, M., H. Horie, M. Arita, and A. Nomoto. 1999. Interaction of poliovirus with its receptor affords a high level of infectivity to the virion in poliovirus infections mediated by the Fc receptor. J. Virol. 731066-1074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC103926</ArticleId><ArticleId IdType="pubmed">9882307</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita, M., S. Koike, J. Aoki, H. Horie, and A. Nomoto. 1998. Interaction of poliovirus with its purified receptor and conformational alteration in the virion. J. Virol. 723578-3586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC109578</ArticleId><ArticleId IdType="pubmed">9557638</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita, M., N. Nagata, N. Iwata, Y. Ami, Y. Suzaki, K. Mizuta, T. Iwasaki, T. Sata, T. Wakita, and H. Shimizu. 2007. An attenuated strain of enterovirus 71 belonging to genotype A showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J. Virol. 819386-9395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1951441</ArticleId><ArticleId IdType="pubmed">17567701</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita, M., N. Nagata, T. Sata, T. Miyamura, and H. Shimizu. 2006. Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon. J. Gen. Virol. 873317-3327.</Citation><ArticleIdList><ArticleId IdType="pubmed">17030866</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita, M., H. Shimizu, N. Nagata, Y. Ami, Y. Suzaki, T. Sata, T. Iwasaki, and T. Miyamura. 2005. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J. Gen. Virol. 861391-1401.</Citation><ArticleIdList><ArticleId IdType="pubmed">15831951</ArticleId></ArticleIdList></Reference><Reference><Citation>Barclay, W., Q. Li, G. Hutchinson, D. Moon, A. Richardson, N. Percy, J. W. Almond, and D. J. Evans. 1998. Encapsidation studies of poliovirus subgenomic replicons. J. Gen. Virol. 791725-1734.</Citation><ArticleIdList><ArticleId IdType="pubmed">9680136</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter, A. G., and A. Cooke. 1993. Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice. Diabetes 421574-1578.</Citation><ArticleIdList><ArticleId IdType="pubmed">8405697</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosma, G. C., R. P. Custer, and M. J. Bosma. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301527-530.</Citation><ArticleIdList><ArticleId IdType="pubmed">6823332</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchard, M. J., D. H. Lam, and V. R. Racaniello. 1995. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J. Virol. 694972-4978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189313</ArticleId><ArticleId IdType="pubmed">7609067</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, B. A., and M. A. Pallansch. 1995. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 39195-205.</Citation><ArticleIdList><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, L. Y., T. Y. Lin, K. H. Hsu, Y. C. Huang, K. L. Lin, C. Hsueh, S. R. Shih, H. C. Ning, M. S. Hwang, H. S. Wang, and C. Y. Lee. 1999. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 3541682-1686.</Citation><ArticleIdList><ArticleId IdType="pubmed">10568570</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, C. S., Y. C. Yao, S. C. Lin, Y. P. Lee, Y. F. Wang, J. R. Wang, C. C. Liu, H. Y. Lei, and C. K. Yu. 2007. Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J. Virol. 818996-9003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1951457</ArticleId><ArticleId IdType="pubmed">17567704</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, H. F., M. H. Chang, B. L. Chiang, and S. T. Jeng. 2006. Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine 242944-2951.</Citation><ArticleIdList><ArticleId IdType="pubmed">16448730</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Y. C., C. K. Yu, Y. F. Wang, C. C. Liu, I. J. Su, and H. Y. Lei. 2004. A murine oral enterovirus 71 infection model with central nervous system involvement. J. Gen. Virol. 8569-77.</Citation><ArticleIdList><ArticleId IdType="pubmed">14718621</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu, C. H., C. Chu, C. C. He, and T. Y. Lin. 2006. Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Microbes Infect. 81671-1678.</Citation><ArticleIdList><ArticleId IdType="pubmed">16815726</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov, M., M. Voroshilova, L. Shindarov, I. Lavrova, L. Gracheva, G. Koroleva, S. Vasilenko, I. Brodvarova, M. Nikolova, S. Gyurova, M. Gacheva, G. Mitov, N. Ninov, E. Tsylka, I. Robinson, M. Frolova, V. Bashkirtsev, L. Martiyanova, and V. Rodin. 1979. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch. Virol. 60329-340.</Citation><ArticleIdList><ArticleId IdType="pubmed">228639</ArticleId></ArticleIdList></Reference><Reference><Citation>Couderc, T., F. Delpeyroux, H. Le Blay, and B. Blondel. 1996. Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating. J. Virol. 70305-312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189818</ArticleId><ArticleId IdType="pubmed">8523541</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 3659-74.</Citation><ArticleIdList><ArticleId IdType="pubmed">886304</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagiwara, A., I. Tagaya, and T. Yoneyama. 1978. Epidemic of hand, foot and mouth disease associated with enterovirus 71 infection. Intervirology 960-63.</Citation><ArticleIdList><ArticleId IdType="pubmed">202573</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala, H., H. Kalimo, J. Bergelson, G. Stanway, and T. Hyypia. 2005. Tissue tropism of recombinant coxsackieviruses in an adult mouse model. J. Gen. Virol. 861897-1907.</Citation><ArticleIdList><ArticleId IdType="pubmed">15958668</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto, I., and A. Hagiwara. 1983. Comparative studies on the neurovirulence of temperature-sensitive and temperature-resistant viruses of enterovirus 71 in monkeys. Acta Neuropathol. (Berlin) 60266-270.</Citation><ArticleIdList><ArticleId IdType="pubmed">6310928</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto, I., and A. Hagiwara. 1982. Pathogenicity of a poliomyelitis-like disease in monkeys infected orally with enterovirus 71: a model for human infection. Neuropathol. Appl. Neurobiol. 8149-156.</Citation><ArticleIdList><ArticleId IdType="pubmed">7048123</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho, M., E. R. Chen, K. H. Hsu, S. J. Twu, K. T. Chen, S. F. Tsai, J. R. Wang, and S. R. Shih. 1999. An epidemic of enterovirus 71 infection in Taiwan. N. Engl. J. Med. 341929-935.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Horie, H., S. Koike, T. Kurata, Y. Sato-Yoshida, I. Ise, Y. Ota, S. Abe, K. Hioki, H. Kato, C. Taya, T. Nomura, S. Hashizume, H. Yonekawa, and A. Nomoto. 1994. Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence. J. Virol. 68681-688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC236503</ArticleId><ArticleId IdType="pubmed">8289371</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, C. C., C. C. Liu, Y. C. Chang, C. Y. Chen, S. T. Wang, and T. F. Yeh. 1999. Neurologic complications in children with enterovirus 71 infection. N. Engl. J. Med. 341936-942.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Ida-Hosonuma, M., T. Iwasaki, T. Yoshikawa, N. Nagata, Y. Sato, T. Sata, M. Yoneyama, T. Fujita, C. Taya, H. Yonekawa, and S. Koike. 2005. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J. Virol. 794460-4469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1061561</ArticleId><ArticleId IdType="pubmed">15767446</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson, C. A., C. Cobbs, J. D. Peduzzi, M. Novak, and C. D. Morrow. 2001. Repetitive intrathecal injections of poliovirus replicons result in gene expression in neurons of the central nervous system without pathogenesis. Hum. Gene Ther. 121827-1841.</Citation><ArticleIdList><ArticleId IdType="pubmed">11589826</ArticleId></ArticleIdList></Reference><Reference><Citation>Karber, G. 1931. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch. Exp. Pathol. Pharm. 162480.</Citation></Reference><Reference><Citation>Kataoka, S., J. Satoh, H. Fujiya, T. Toyota, R. Suzuki, K. Itoh, and K. Kumagai. 1983. Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes 32247-253.</Citation><ArticleIdList><ArticleId IdType="pubmed">6298042</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauder, S. E., and V. R. Racaniello. 2004. Poliovirus tropism and attenuation are determined after internal ribosome entry. J. Clin. Investig. 1131743-1753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC420511</ArticleId><ArticleId IdType="pubmed">15199409</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamura, N., M. Kohara, S. Abe, T. Komatsu, K. Tago, M. Arita, and A. Nomoto. 1989. Determinants in the 5&#x2032; noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J. Virol. 631302-1309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC247827</ArticleId><ArticleId IdType="pubmed">2536835</ArticleId></ArticleIdList></Reference><Reference><Citation>Kew, O. M., R. W. Sutter, E. M. de Gourville, W. R. Dowdle, and M. A. Pallansch. 2005. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu. Rev. Microbiol. 59587-635.</Citation><ArticleIdList><ArticleId IdType="pubmed">16153180</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirchgessner, C. U., C. K. Patil, J. W. Evans, C. A. Cuomo, L. M. Fried, T. Carter, M. A. Oettinger, and J. M. Brown. 1995. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 2671178-1183.</Citation><ArticleIdList><ArticleId IdType="pubmed">7855601</ArticleId></ArticleIdList></Reference><Reference><Citation>Koike, S., H. Horie, I. Ise, A. Okitsu, M. Yoshida, N. Iizuka, K. Takeuchi, T. Takegami, and A. Nomoto. 1990. The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J. 93217-3224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC552052</ArticleId><ArticleId IdType="pubmed">2170108</ArticleId></ArticleIdList></Reference><Reference><Citation>Koike, S., C. Taya, T. Kurata, S. Abe, I. Ise, H. Yonekawa, and A. Nomoto. 1991. Transgenic mice susceptible to poliovirus. Proc. Natl. Acad. Sci. USA 88951-955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC50932</ArticleId><ArticleId IdType="pubmed">1846972</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu, H., Y. Shimizu, Y. Takeuchi, H. Ishiko, and H. Takada. 1999. Outbreak of severe neurologic involvement associated with enterovirus 71 infection. Pediatr. Neurol. 2017-23.</Citation><ArticleIdList><ArticleId IdType="pubmed">10029254</ArticleId></ArticleIdList></Reference><Reference><Citation>La Monica, N., J. W. Almond, and V. R. Racaniello. 1987. A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans. J. Virol. 612917-2920.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC255821</ArticleId><ArticleId IdType="pubmed">3039178</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, C. C., W. C. Lian, M. Butler, and S. C. Wu. 2007. High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. Vaccine 2519-24.</Citation><ArticleIdList><ArticleId IdType="pubmed">16919374</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, M. L., Y. P. Lee, Y. F. Wang, H. Y. Lei, C. C. Liu, S. M. Wang, I. J. Su, J. R. Wang, T. M. Yeh, S. H. Chen, and C. K. Yu. 2005. Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 863263-3269.</Citation><ArticleIdList><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum, L. C., K. T. Wong, S. K. Lam, K. B. Chua, A. Y. Goh, W. L. Lim, B. B. Ong, G. Paul, S. AbuBakar, and M. Lambert. 1998. Fatal enterovirus 71 encephalomyelitis. J. Pediatr. 133795-798.</Citation><ArticleIdList><ArticleId IdType="pubmed">9842048</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin, A., D. Benichou, T. Couderc, J. M. Hogle, C. Wychowski, S. Van der Werf, and M. Girard. 1991. Use of type 1/type 2 chimeric polioviruses to study determinants of poliovirus type 1 neurovirulence in a mouse model. Virology 180648-658.</Citation><ArticleIdList><ArticleId IdType="pubmed">1846492</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin, A., C. Wychowski, T. Couderc, R. Crainic, J. Hogle, and M. Girard. 1988. Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice. EMBO J. 72839-2847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC457076</ArticleId><ArticleId IdType="pubmed">2460345</ArticleId></ArticleIdList></Reference><Reference><Citation>McGoldrick, A., A. J. Macadam, G. Dunn, A. Rowe, J. Burlison, P. D. Minor, J. Meredith, D. J. Evans, and J. W. Almond. 1995. Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus. J. Virol. 697601-7605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189699</ArticleId><ArticleId IdType="pubmed">7494267</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn, P. C. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 2691-107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelsohn, C. L., E. Wimmer, and V. R. Racaniello. 1989. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56855-865.</Citation><ArticleIdList><ArticleId IdType="pubmed">2538245</ArticleId></ArticleIdList></Reference><Reference><Citation>Minor, P. D. 1992. The molecular biology of polio vaccines. J. Gen. Virol. 733065-3077.</Citation><ArticleIdList><ArticleId IdType="pubmed">1335021</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray, M. G., J. Bradley, X. F. Yang, E. Wimmer, E. G. Moss, and V. R. Racaniello. 1988. Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. Science 241213-215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3908517</ArticleId><ArticleId IdType="pubmed">2838906</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata, N., T. Iwasaki, Y. Ami, A. Harashima, I. Hatano, Y. Suzaki, K. Yoshii, T. Yoshii, A. Nomoto, and T. Kurata. 2001. Comparison of neuropathogenicity of poliovirus type 3 in transgenic mice bearing the poliovirus receptor gene and cynomolgus monkeys. Vaccine 193201-3208.</Citation><ArticleIdList><ArticleId IdType="pubmed">11312016</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata, N., T. Iwasaki, Y. Ami, Y. Tano, A. Harashima, Y. Suzaki, Y. Sato, H. Hasegawa, T. Sata, T. Miyamura, and H. Shimizu. 2004. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J. Gen. Virol. 852981-2989.</Citation><ArticleIdList><ArticleId IdType="pubmed">15448361</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata, N., H. Shimizu, Y. Ami, Y. Tano, A. Harashima, Y. Suzaki, Y. Sato, T. Miyamura, T. Sata, and T. Iwasaki. 2002. Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J. Med. Virol. 67207-216.</Citation><ArticleIdList><ArticleId IdType="pubmed">11992581</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijhuis, M., N. van Maarseveen, R. Schuurman, S. Verkuijlen, M. de Vos, K. Hendriksen, and A. M. van Loon. 2002. Rapid and sensitive routine detection of all members of the genus enterovirus in different clinical specimens by real-time PCR. J. Clin. Microbiol. 403666-3670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC130891</ArticleId><ArticleId IdType="pubmed">12354863</ArticleId></ArticleIdList></Reference><Reference><Citation>Omata, T., M. Kohara, S. Kuge, T. Komatsu, S. Abe, B. L. Semler, A. Kameda, H. Itoh, M. Arita, E. Wimmer, and A. Nomoto. 1986. Genetic analysis of the attenuation phenotype of poliovirus type 1. J. Virol. 58348-358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC252919</ArticleId><ArticleId IdType="pubmed">3009852</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul, A. V., J. Mugavero, J. Yin, S. Hobson, S. Schultz, J. H. van Boom, and E. Wimmer. 2000. Studies on the attenuation phenotype of polio vaccines: poliovirus RNA polymerase derived from Sabin type 1 sequence is temperature sensitive in the uridylylation of VPg. Virology 27272-84.</Citation><ArticleIdList><ArticleId IdType="pubmed">10873750</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulli, T., P. Koskimies, and T. Hyypia. 1995. Molecular comparison of coxsackie A virus serotypes. Virology 21230-38.</Citation><ArticleIdList><ArticleId IdType="pubmed">7676647</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren, R. B., F. Costantini, E. J. Gorgacz, J. J. Lee, and V. R. Racaniello. 1990. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 63353-362.</Citation><ArticleIdList><ArticleId IdType="pubmed">2170026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren, R. B., E. G. Moss, and V. R. Racaniello. 1991. Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J. Virol. 651377-1382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC239915</ArticleId><ArticleId IdType="pubmed">1847458</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezapkin, G. V., L. Fan, D. M. Asher, M. R. Fibi, E. M. Dragunsky, and K. M. Chumakov. 1999. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype. Virology 258152-160.</Citation><ArticleIdList><ArticleId IdType="pubmed">10329577</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabin, A. B. 1965. Oral poliovirus vaccine. History of its development and prospects for eradication of poliomyelitis. JAMA 194872-876.</Citation><ArticleIdList><ArticleId IdType="pubmed">5321495</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed., p 13.19-13.25. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.</Citation></Reference><Reference><Citation>Schmidt, N. J., E. H. Lennette, and H. H. Ho. 1974. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 129304-309.</Citation><ArticleIdList><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih, S. R., M. C. Tsai, S. N. Tseng, K. F. Won, K. S. Shia, W. T. Li, J. H. Chern, G. W. Chen, C. C. Lee, Y. C. Lee, K. C. Peng, and Y. S. Chao. 2004. Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone. Antimicrob. Agents Chemother. 483523-3529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC514779</ArticleId><ArticleId IdType="pubmed">15328120</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiroki, K., T. Ishii, T. Aoki, Y. Ota, W. X. Yang, T. Komatsu, Y. Ami, M. Arita, S. Abe, S. Hashizume, and A. Nomoto. 1997. Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA. J. Virol. 711-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191017</ArticleId><ArticleId IdType="pubmed">8985316</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth, M., J. Tate, E. Hoey, C. Lyons, S. Martin, and D. Stuart. 1995. Implications for viral uncoating from the structure of bovine enterovirus. Nat. Struct. Biol. 2224-231.</Citation><ArticleIdList><ArticleId IdType="pubmed">7773791</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan, C. S., and M. J. Cardosa. 2007. High-titred neutralizing antibodies to human enterovirus 71 preferentially bind to the N-terminal portion of the capsid protein VP1. Arch. Virol. 1521069-1073.</Citation><ArticleIdList><ArticleId IdType="pubmed">17318736</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardy-Panit, M., B. Blondel, A. Martin, F. Tekaia, F. Horaud, and F. Delpeyroux. 1993. A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice. J. Virol. 674630-4638.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC237848</ArticleId><ArticleId IdType="pubmed">8392604</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung, W. S., S. A. Bakar, Z. Sekawi, and R. Rosli. 2007. DNA vaccine constructs against enterovirus 71 elicit immune response in mice. Genet. Vaccines Ther. 56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3225814</ArticleId><ArticleId IdType="pubmed">17445254</ArticleId></ArticleIdList></Reference><Reference><Citation>Utagawa, E. T., E. Nakazawa, K. Matsuo, I. Oishi, N. Takeda, and T. Miyamura. 2002. Application of an automated specimen search system installed in a transmission electron microscope for the detection of caliciviruses in clinical specimens. J. Virol. Methods 10049-56.</Citation><ArticleIdList><ArticleId IdType="pubmed">11742652</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner-Ballon, O., H. Chagraoui, E. Prina, M. Tulliez, G. Milon, H. Raslova, J. L. Villeval, W. Vainchenker, and S. Giraudier. 2006. Monocyte/macrophage dysfunctions do not impair the promotion of myelofibrosis by high levels of thrombopoietin. J. Immunol. 1766425-6433.</Citation><ArticleIdList><ArticleId IdType="pubmed">16709799</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, S. M., H. Y. Lei, K. J. Huang, J. M. Wu, J. R. Wang, C. K. Yu, I. J. Su, and C. C. Liu. 2003. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J. Infect. Dis. 188564-570.</Citation><ArticleIdList><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, S. M., C. C. Liu, H. W. Tseng, J. R. Wang, C. C. Huang, Y. J. Chen, Y. J. Yang, S. J. Lin, and T. F. Yeh. 1999. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin. Infect. Dis. 29184-190.</Citation><ArticleIdList><ArticleId IdType="pubmed">10433583</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Y. F., C. T. Chou, H. Y. Lei, C. C. Liu, S. M. Wang, J. J. Yan, I. J. Su, J. R. Wang, T. M. Yeh, S. H. Chen, and C. K. Yu. 2004. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J. Virol. 787916-7924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, T. C., Y. F. Wang, Y. P. Lee, J. R. Wang, C. C. Liu, S. M. Wang, H. Y. Lei, I. J. Su, and C. K. Yu. 2007. Immunity to avirulent enterovirus 71 and coxsackie A16 virus protect against enterovirus 71 infection in mice. J. Virol. 8110310-10315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2045469</ArticleId><ArticleId IdType="pubmed">17626076</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, C. K., C. C. Chen, C. L. Chen, J. R. Wang, C. C. Liu, J. J. Yan, and I. J. Su. 2000. Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J. Biomed. Sci. 7523-528.</Citation><ArticleIdList><ArticleId IdType="pubmed">11060501</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>